Skip to main content
SpringerLink
Log in

Levetiracetam

Worsening of chronic post-hypoxic myoclonus (Lance-Adams syndrome) with functional decline following a decrease in the dose of levetiracetam (rebound effect): case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Olsen DG, et al. Triple pharmacotherapy in the treatment of refractory chronic posthypoxic myoclonus (Lance-Adams syndrome): A case report. P M and R - The Journal of Injury, Function and Rehabilitation 11 (Suppl. 2): S133, Nov 2019. Available from: URL: http://doi.org/10.1002/pmrj.12271 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levetiracetam. Reactions Weekly 1808, 176 (2020). https://doi.org/10.1007/s40278-020-79653-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79653-7

Search

Navigation